Literature DB >> 3489009

Specific bioactivities of monocyte-derived interleukin 1 alpha and interleukin 1 beta are similar to each other on cultured murine thymocytes and on cultured human connective tissue cells.

E A Rupp, P M Cameron, C S Ranawat, J A Schmidt, E K Bayne.   

Abstract

In this report we compare the bioactivities of pure, human monocyte-derived interleukin 1 (IL-1) alpha and beta in the standard murine thymocyte proliferation assay, a human dermal fibroblast proliferation assay, and in an assay measuring stimulation of prostaglandin E2 (PGE2) release from human rheumatoid synoviocytes. In each case the different species of IL-1 produced saturable stimulation and gave similar dose response curves. Half-maximal stimulation was observed at average IL-1 concentrations of 29 pM in the thymocyte assay, 2 pM in the dermal fibroblast proliferation assay, and 5 pM in the synovial cell assay. Our results show that native, monocyte-derived IL-1 alpha and IL-1 beta are both potent stimulators of connective tissue cells and that the specific bioactivities of these molecules are similar to each other in tests on human connective tissue cells, as well as on murine lymphoid cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3489009      PMCID: PMC423684          DOI: 10.1172/JCI112649

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Partial purification of human lymphocyte-activating factor (LAF) by ultrafiltration and electrophoretic techniques.

Authors:  L B Lachman; M P Hacker; R E Handschumacher
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

2.  Interleukin 1, a potential regulator of fibroblast proliferation.

Authors:  J A Schmidt; S B Mizel; D Cohen; I Green
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

3.  Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1. A potential role for interleukin 1 in the pathogenesis of silicosis.

Authors:  J A Schmidt; C N Oliver; J L Lepe-Zuniga; I Green; I Gery
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

4.  Rheumatoid synovial cell morphologic changes induced by a mononuclear cell factor in culture.

Authors:  D G Baker; J M Dayer; M Roelke; H R Schumacher; S M Krane
Journal:  Arthritis Rheum       Date:  1983-01

5.  In vitro activation of human chondrocytes and synoviocytes by a human interleukin-1-like factor.

Authors:  M B McGuire-Goldring; J E Meats; D D Wood; E J Ihrie; N M Ebsworth; R G Russell
Journal:  Arthritis Rheum       Date:  1984-06

Review 6.  Interleukin-1.

Authors:  C A Dinarello
Journal:  Rev Infect Dis       Date:  1984 Jan-Feb

7.  An interleukin 1 like factor stimulates bone resorption in vitro.

Authors:  M Gowen; D D Wood; E J Ihrie; M K McGuire; R G Russell
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

8.  Interleukin 1 stimulation of collagenase production by cultured fibroblasts.

Authors:  A E Postlethwaite; L B Lachman; C L Mainardi; A H Kang
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

9.  Purification to homogeneity and amino acid sequence analysis of two anionic species of human interleukin 1.

Authors:  P M Cameron; G A Limjuco; J Chin; L Silberstein; J A Schmidt
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

10.  Purification and partial biochemical characterization of normal human interleukin 1.

Authors:  J A Schmidt
Journal:  J Exp Med       Date:  1984-09-01       Impact factor: 14.307

View more
  16 in total

1.  High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries.

Authors:  S D Yanofsky; D N Baldwin; J H Butler; F R Holden; J W Jacobs; P Balasubramanian; J P Chinn; S E Cwirla; E Peters-Bhatt; E A Whitehorn; E H Tate; A Akeson; T L Bowlin; W J Dower; R W Barrett
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Identification of a high-affinity receptor for interleukin 1 alpha and interleukin 1 beta on cultured human rheumatoid synovial cells.

Authors:  J Chin; E Rupp; P M Cameron; K L MacNaul; P A Lotke; M J Tocci; J A Schmidt; E K Bayne
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

3.  Interleukin-1 gene expression in rabbit vascular tissue in vivo.

Authors:  S K Clinton; J C Fleet; H Loppnow; R N Salomon; B D Clark; J G Cannon; A R Shaw; C A Dinarello; P Libby
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

4.  Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.

Authors:  G Buchan; K Barrett; M Turner; D Chantry; R N Maini; M Feldmann
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

5.  Human recombinant interleukin-1 regulates cellular mRNA levels of dermatan sulphate proteoglycan core protein.

Authors:  J Heino; V M Kähäri; A Mauviel; T Krusius
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

6.  Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1 beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro.

Authors:  C P Maury; L C Andersson; A M Teppo; S Partanen; E Juvonen
Journal:  Ann Rheum Dis       Date:  1988-12       Impact factor: 19.103

7.  Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes.

Authors:  M B Goldring; J Birkhead; L J Sandell; T Kimura; S M Krane
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

8.  Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids.

Authors:  P Libby; S J Warner; G B Friedman
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

9.  Differential responses of old human cartilage explants to synovial- and mononuclear-cell factors.

Authors:  O Huber-Bruning; B Wilbrink; J E Vernooij; J W Bijlsma; W den Otter; J Huber
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

10.  Determination of the minimum polypeptide lengths of the functionally active sites of human interleukins 1 alpha and 1 beta.

Authors:  B Mosley; S K Dower; S Gillis; D Cosman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.